Logo image of CPZ

CALAMOS LNG/SHRT EQTY & DYN (CPZ) Stock Price, Quote, News and Overview

NASDAQ:CPZ - Nasdaq - US12812C1062 - Currency: USD

15.3  -0.03 (-0.2%)

Fundamental Rating

1

CPZ gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of CPZ have multiple concerns. CPZ is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CPZ had positive earnings in the past year.
In the past year CPZ has reported a negative cash flow from operations.
In multiple years CPZ reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CPZ reported negative operating cash flow in multiple years.
CPZ Yearly Net Income VS EBIT VS OCF VS FCFCPZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 100M -100M -200M -300M

1.2 Ratios

Industry RankSector Rank
ROA -2.18%
ROE -3.82%
ROIC N/A
ROA(3y)3.33%
ROA(5y)N/A
ROE(3y)5.75%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CPZ Yearly ROA, ROE, ROICCPZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

CPZ's Operating Margin has improved in the last couple of years.
The Profit Margin and Operating Margin and Gross Margin are not available for CPZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y4.76%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CPZ Yearly Profit, Operating, Gross MarginsCPZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 100 -100 200 300

0

2. Health

2.1 Basic Checks

The number of shares outstanding for CPZ remains at a similar level compared to 1 year ago.
Compared to 1 year ago, CPZ has a worse debt to assets ratio.
CPZ Yearly Shares OutstandingCPZ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M
CPZ Yearly Total Debt VS Total AssetsCPZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.28, we must say that CPZ is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.62 indicates that CPZ is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z 0.28
ROIC/WACCN/A
WACCN/A
CPZ Yearly LT Debt VS Equity VS FCFCPZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 0.63 indicates that CPZ may have some problems paying its short term obligations.
A Quick Ratio of 0.63 indicates that CPZ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.63
CPZ Yearly Current Assets VS Current LiabilitesCPZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 50M 100M 150M 200M 250M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 125.61% over the past year.
CPZ shows a strong growth in Revenue. In the last year, the Revenue has grown by 465.82%.
The Revenue has been growing by 41.76% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)125.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.98%
Revenue 1Y (TTM)465.82%
Revenue growth 3Y41.76%
Revenue growth 5YN/A
Sales Q2Q%127.44%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CPZ Yearly Revenue VS EstimatesCPZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 0 20M 40M 60M

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.32, the valuation of CPZ can be described as expensive.
When comparing the Price/Earnings ratio of CPZ to the average of the S&P500 Index (28.98), we can say CPZ is valued inline with the index average.
Industry RankSector Rank
PE 27.32
Fwd PE N/A
CPZ Price Earnings VS Forward Price EarningsCPZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CPZ Per share dataCPZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

CPZ has a Yearly Dividend Yield of 12.22%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.46, CPZ pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.22%

5.2 History

CPZ has been paying a dividend for over 5 years, so it has already some track record.
CPZ has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years4
CPZ Yearly Dividends per shareCPZ Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CPZ has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-247.38%
EPS Next 2YN/A
EPS Next 3YN/A
CPZ Yearly Income VS Free CF VS DividendCPZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 0 100M -100M -200M -300M

CALAMOS LNG/SHRT EQTY & DYN

NASDAQ:CPZ (4/29/2025, 8:00:00 PM)

15.3

-0.03 (-0.2%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners40.91%
Inst Owner Change0.19%
Ins Owners0.68%
Ins Owner Change-316.04%
Market Cap300.34M
Analysts0
Price TargetN/A
Short Float %0.38%
Short Ratio0.99
Dividend
Industry RankSector Rank
Dividend Yield 12.22%
Yearly Dividend1.68
Dividend Growth(5Y)N/A
DP-247.38%
Div Incr Years0
Div Non Decr Years4
Ex-Date04-11 2025-04-11 (0.14)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 27.32
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.86
P/tB 0.86
EV/EBITDA N/A
EPS(TTM)0.56
EY3.66%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.29
FCFYN/A
OCF(TTM)-3.29
OCFYN/A
SpS-0.88
BVpS17.77
TBVpS17.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.18%
ROE -3.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.33%
ROA(5y)N/A
ROE(3y)5.75%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y4.76%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover-0.03
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.63
Quick Ratio 0.63
Altman-Z 0.28
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)465.82%
Revenue growth 3Y41.76%
Revenue growth 5YN/A
Sales Q2Q%127.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-175.25%
EBIT growth 3Y48.51%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1062.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1062.69%
OCF growth 3YN/A
OCF growth 5YN/A